Detalhe da pesquisa
1.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med
; 389(23): 2162-2174, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055253
2.
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer.
Br J Cancer
; 130(6): 941-950, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245661
3.
A systematic review of ethnic minority participation in randomised controlled trials of systemic therapies for gynecological cancers.
Gynecol Oncol
; 184: 178-189, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330832
4.
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC).
Int J Gynecol Cancer
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38760075
5.
Homologous recombination deficiency in newly diagnosed FIGO stage III/IV high-grade epithelial ovarian cancer: a multi-national observational study.
Int J Gynecol Cancer
; 33(8): 1253-1259, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37072323
6.
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.
N Engl J Med
; 381(25): 2403-2415, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562800
7.
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial.
BMC Med
; 20(1): 59, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35144591
8.
British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic.
Int J Gynecol Cancer
; 32(1): 9-14, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34795019
9.
ICON 9-an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy.
Int J Gynecol Cancer
; 31(1): 134-138, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097567
10.
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.
Int J Gynecol Cancer
; 31(2): 272-278, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468564
11.
Results of a phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumours.
Br J Cancer
; 122(4): 483-490, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813938
12.
Assessment and management of diarrhea following VEGF receptor TKI treatment in patients with ovarian cancer.
Gynecol Oncol
; 150(1): 173-179, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29627080
13.
A source of hope for platinum-resistant ovarian cancer?
Lancet
; 397(10271): 254-256, 2021 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485431
14.
A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol.
BMC Cancer
; 14: 983, 2014 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25526776
15.
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK.
Cancers (Basel)
; 15(4)2023 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831615
16.
British Gynaecological Cancer Society Recommendations for Evidence Based, Population Data Derived Quality Performance Indicators for Ovarian Cancer.
Cancers (Basel)
; 15(2)2023 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36672287
17.
PARPs: All for One and One for All? Enhancing Diversity in Clinical Trials.
Clin Cancer Res
; 28(11): 2201-2203, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357469
18.
Epidermal growth factor receptor blockers for the treatment of ovarian cancer.
Cochrane Database Syst Rev
; (10): CD007927, 2011 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21975775
19.
Angiogenesis inhibitors for the treatment of ovarian cancer.
Cochrane Database Syst Rev
; (9): CD007930, 2011 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21901715
20.
Randomised phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancer (OCTOVA): a study protocol.
BMJ Open
; 11(1): e041463, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452192